Anna Kasatova
Overview
Explore the profile of Anna Kasatova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taskaeva I, Kasatova A, Razumov I, Bgatova N, Taskaev S
J Appl Toxicol
. 2023 Dec;
44(5):712-719.
PMID: 38146629
Boron neutron capture therapy is a perspective selective technology for the destruction of cancer cells, while the use of lithium instead of boron may represent a new and promising vector...
2.
Potseleev V, Uspenskii S, Trofimchuk E, Bolshakova A, Kasatova A, Kasatov D, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003683
In this study, approaches to the synthesis of complex compound of gold with cysteine [AuCys] for measuring absorbed dose in boron neutron capture therapy (BNCT) were developed. The dependence of...
3.
Taskaeva I, Kasatova A, Surodin D, Bgatova N, Taskaev S
Life (Basel)
. 2023 Feb;
13(2).
PMID: 36836875
Boron neutron capture therapy (BNCT) is one of the promising treatment methods for malignant melanoma. The main issue of this technology is the insufficient selectivity of B accumulation in tumor...
4.
Zaboronok A, Khaptakhanova P, Uspenskii S, Bekarevich R, Mechetina L, Volkova O, et al.
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456595
Sufficient boron-10 isotope (B) accumulation by tumor cells is one of the main requirements for successful boron neutron capture therapy (BNCT). The inability of the clinically registered B-containing borophenylalanine (BPA)...
5.
Kanygin V, Kichigin A, Zaboronok A, Kasatova A, Petrova E, Tsygankova A, et al.
Biology (Basel)
. 2022 Jan;
11(1).
PMID: 35053138
(1) Background: accelerator-based neutron sources are a new frontier for BNCT but many technical issues remain. We aimed to study such issues and results in larger-animal BNCT (cats and dogs)...
6.
Zaboronok A, Taskaev S, Volkova O, Mechetina L, Kasatova A, Sycheva T, et al.
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575566
Boron neutron capture therapy (BNCT) is an anticancer modality realized through B accumulation in tumor cells, neutron irradiation of the tumor, and decay of boron atoms with the release of...
7.
Kanygin V, Zaboronok A, Taskaeva I, Zavjalov E, Mukhamadiyarov R, Kichigin A, et al.
J Fluoresc
. 2020 Oct;
31(1):73-83.
PMID: 33078252
Boron neutron capture therapy (BNCT), a binary cancer therapeutic modality, has moved to a new phase since development of accelerator-based neutron sources and establishment of BNCT centers in Finland and...
8.
Zavjalov E, Zaboronok A, Kanygin V, Kasatova A, Kichigin A, Mukhamadiyarov R, et al.
Int J Radiat Biol
. 2020 Apr;
96(7):868-878.
PMID: 32339057
To evaluate the efficacy of boron neutron capture therapy (BNCT) for a heterotopic U87 glioblastoma model in SCID mice using boron phenylalanine (BPA), sodium borocaptate (BSH) and liposomal BSH as...